Zdrowie i gospodarka · 09/04/2002

FDA Requests Comments on Scheduling of Five Drug Substances

The FDA is seeking public input on the potential abuse liability and diversion of five drug substances, including Amfepramone, Amineptine, Buprenorphine, Delta-9-tetrahydrocannabinol (dronabinol), and Tramadol, in preparation for a response to the World Health Organization (WHO).